Healthcare

SCYNEXIS Presents Positive Data from Phase 3 CANDLE Nested Sub-Study Investigating Ibrexafungerp in Women with Recurrent Yeast Infections Who Failed Fluconazole During the ISSVD XXVI World Congress and International Vulvovaginal Disease Update

Staff July 19, 2022

Data show that 71% of 24 patients with recurrent vulvovaginal candidiasis (RVVC) who failed to respond to a three-day regimen...

Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer

Staff July 19, 2022

Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN),...

Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)

Staff July 19, 2022

CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to Placebo in Quickly Reducing Agitation...

PetVivo Holdings, Inc. Announces Formation of Nonprofit PetVivo Cares To Advance The Health & Well-Being of Companion Animals

Staff July 19, 2022

MINNEAPOLIS, July 19, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company...

LifeMD Announces Continued and Rapid Expansion of Virtual Primary Care To over 200 Conditions

Staff July 19, 2022

LifeMD’s Virtual Primary Care platform now addresses over 200 conditions with its robust infrastructure of doctors, medical professionals, pharmacies, and...

Quipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th – 11th

Staff July 19, 2022

Webcasted Presentation to be Held Thursday August 11thCINCINNATI, July 19, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”)...

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression

Staff July 19, 2022

Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patientsMALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE)...

Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer

Staff July 19, 2022

BOSTON, July 19, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives...

Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis’ Across Europe

Staff July 19, 2022

‘WeCare-MedicalCannabis’ A Comprehensive Resource for Medical Cannabis Education is Now Available in English, German, French, and PortugueseNEUMÜNSTER, Germany, July 19,...

Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs

Staff July 19, 2022

Company aims to increase health equity by developing more accessible treatment modalities better suited for existing healthcare infrastructureDENVER, July 19,...

Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board

Staff July 19, 2022

Renowned Experts to Support ColoAlert’s U.S. Pivotal Clinical Trial and Development of Additional Cancer DiagnosticsDr. Wang is the GI (Gastrointestinal)...

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

Staff July 19, 2022

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION19 July 2022, 07:00 am CEST DSR (Direct Sodium Removal) heart failure drug development: Completed...

Doug Kohrs appointed to Sequana Medical Board of Directors

Staff July 19, 2022

Highly experienced US medtech leader brings more than 40 years’ experience Ghent, Belgium – 19 July 2022 – Sequana Medical...

Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance

Staff July 19, 2022

Ad hoc announcement pursuant to Art. 53 LR Q2 sales grew +5% cc1 (-1% USD) Innovative Medicines (IM) sales grew...

Healthcare

SCYNEXIS Presents Positive Data from Phase 3 CANDLE Nested Sub-Study Investigating Ibrexafungerp in Women with Recurrent Yeast Infections Who Failed Fluconazole During the ISSVD XXVI World Congress and International Vulvovaginal Disease Update

Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer

Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)

PetVivo Holdings, Inc. Announces Formation of Nonprofit PetVivo Cares To Advance The Health & Well-Being of Companion Animals

LifeMD Announces Continued and Rapid Expansion of Virtual Primary Care To over 200 Conditions

Quipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th – 11th

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression

Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer

Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis’ Across Europe

Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs

Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board

Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update

Doug Kohrs appointed to Sequana Medical Board of Directors

Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance

180 Life Sciences Corp. Announces $6.5 Million Registered Direct Offering

HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid

DAXOR COMPLETES NIH FUNDED I-CORPS PROGRAM FOR COMMERCIALIZATION OF CLINICAL DECISION SUPPORT SOFTWARE

GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians

George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer

FSD Pharma Files Amended and Restated Material Change Report

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

You may have missed